Novo Nordisk to initiate study assessing CagriSema vs Tirzepatide Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Tirzepatide: a new low for bodyweight and blood glucose The Lancet Diabetes & Endocrinology Cagrilintide C194H312N54O59S2 CID 171397054 PubChem Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management